Survodutide Peptide
$182.00
Research-grade Survodutide (BI 456906) is a synthetic 29-amino-acid dual agonist peptide targeting GLP-1R and GCGR receptors. For Research Use Only. Not for human use.
Discount per Quantity
| Quantity | 5 – 9 | 10 + |
|---|---|---|
| Discount | 5% | 10% |
| Price | $172.90 | $163.80 |
Orders over $200: FREE USPS Priority shipping.
- >99% purity — HPLC + MS verified
- Cold-pack insulated mailers
- Discreet US shipping (2–5 days)
- COA available on request
Research Use Only. Not for human consumption. Sold strictly for laboratory and research use.
Survodutide (BI 456906) is an investigational unimolecular dual agonist developed by Boehringer Ingelheim (licensed from Zealand Pharma) that activates both the glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR). Based on a modified glucagon backbone with C18 fatty acid acylation supporting once-weekly dosing, it is currently being evaluated in Phase 3 clinical trials (SYNCHRONIZE program) and represents an area of active incretin receptor research. This research-grade lyophilized powder is synthesized under strict quality controls and provided with full analytical documentation. For Research Use Only. Not for human use.
Key Scientific Attributes
- High-purity Survodutide (≥98% by HPLC/MS, acetate salt form)
- Verified 29-amino-acid glucagon-based sequence with C18 diacid lipidation
- Lyophilized formulation for maximum long-term stability
- Full Certificate of Analysis (COA) with HPLC, MS, receptor-binding assays (GLP-1R/GCGR EC50), and endotoxin testing
- Manufactured in GMP-aligned, ISO-compliant facilities
- Suitable for dual-agonist receptor signaling studies and related in vitro pathway research
Research Context (Based on published clinical/preclinical literature; not therapeutic claims.)
- Dual GLP-1R/GCGR activation profile as described in peer-reviewed pharmacological studies (pubmed.ncbi.nlm.nih.gov)
- Pharmacological profiling and biomarker characterization published in the scientific literature
- Subject of ongoing Phase 3 investigation (SYNCHRONIZE-2) in peer-reviewed research settings (pubmed.ncbi.nlm.nih.gov)
- Evaluated across metabolic, hepatic, and receptor signaling research models in published literature
Why Researchers Choose Nationwide Peptides Survodutide
- Exact clinical-sequence match to BI 456906 with verified dual-receptor potency
- Transparent analytical data (HPLC >98%, MS confirmation of lipidation)
- Trusted by pharmacology and molecular biology laboratories
- Competitive research pricing with bulk options
For Research Use Only. Not for human use.
| SKU | survodutide |
|---|---|
| Category | Peptides |
| Purity | >99% (HPLC + MS verified) |
| Form | Lyophilized powder |
| Origin | Synthesized in the USA |
Certificate of Analysis
Every lot is verified by reverse-phase HPLC for purity and by mass spectrometry for identity. A current COA is available on request — email sales@limitlesslifenootropics.st with the lot number printed on your vial.
- HPLC purity: >99%
- Identity confirmed by ESI-MS
- Lyophilized, sterile-filtered solutions where applicable
- Stored at −20°C until shipment
Shipping & handling
Orders placed before 2pm CT ship the same business day in cold-pack insulated mailers. USPS Priority delivery in 2–5 business days. Free shipping on US orders over $200.
Frequently asked questions
How should I reconstitute this peptide?
Use bacteriostatic water for short-term lab storage. Direct the diluent down the side of the vial, swirl gently — do not shake.
What is the shelf life?
Lyophilized peptide stored at −20°C is stable for 24+ months. Reconstituted peptide should be refrigerated and used within 2–4 weeks.
Do you ship internationally?
We currently ship within the United States only. International researchers should contact our bulk team for institutional quotes.
Frequently bought together
Reviews
There are no reviews yet.